SCHEMBL10077913

SCHEMBL10077913

C[C@@H]1C(O)[C@H](OCc2ccccc2)OC(COC(=O)C(C)(C)C)[C@@H]1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LGALS8 O00214 1/20 0.39
▸ PRKCA P17252 1/20 0.37
▸ PRKCD Q05655 1/20 0.37
▸ SSTR5 P35346 2/20 0.37
▸ FGF1 P05230 2/20 0.36
▸ FGF2 P09038 2/20 0.36
▸ VEGFA P15692 2/20 0.36
▸ HPSE Q9Y251 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ NT5E P21589 1/20 0.36
▸ TACR2 P21452 1/20 0.36
▸ KMT2A Q03164 1/20 0.35
▸ SSTR1 P30872 1/20 0.35
▸ SSTR2 P30874 1/20 0.35
▸ SSTR4 P31391 1/20 0.35
▸ SSTR3 P32745 1/20 0.35
▸ SLC6A2 P23975 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ PTPN1 P18031 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10077888 0.90 LGALS8 (0.37) LGALS8PRKCAPRKCDSSTR5FGF1
SCHEMBL2629592 0.87 LGALS8 (0.48) LGALS8PRKCAPRKCDSSTR5FGF1
SCHEMBL14075622 0.87 LGALS8 (0.48) LGALS8PRKCAPRKCDSSTR5FGF1
SCHEMBL14409788 0.87 LGALS8 (0.48) LGALS8PRKCAPRKCDSSTR5FGF1
SCHEMBL10077887 0.85 LGALS8 (0.41) LGALS8PRKCAPRKCDSSTR5FGF1
SCHEMBL6552374 0.84 TACR2 (0.43) LGALS8SSTR5FGF1FGF2VEGFA
SCHEMBL14683528 0.82 FGF1 (0.43) LGALS8FGF1FGF2VEGFAHPSE
SCHEMBL14075626 0.82 LGALS8 (0.42) LGALS8PRKCAPRKCDSSTR5FGF1
SCHEMBL2629582 0.82 LGALS8 (0.42) LGALS8PRKCAPRKCDSSTR5FGF1
SCHEMBL472852 0.82 LGALS8 (0.42) LGALS8PRKCAPRKCDSSTR5FGF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399656-B2 Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides OTSUKA CHEMICAL CO., LTD. (JP) 2013-03-19 — — US disclosed
US-20120035345-A1 PROCESS FOR PREPARING GLYCOPEPTIDES HAVING ASPARAGINE-LINKED OLIGOSACCHARIDES, AND THE GLYCOPEPTIDES OTSUKA CHEMICAL CO., LTD. (JP) 2012-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035345-A1 PROCESS FOR PREPARING GLYCOPEPTIDES HAVING ASPARAGINE-LINKED OLIGOSACCHARIDES, AND THE GLYCOPEPTIDES ASNS, BSG, ANPEP LGALS8 132/4885PRKCA 3238/4885PRKCD 3736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback